PharmaCorp Rx Inc. PCRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -766.00K | -1.16M | -1.07M | 123.00K | -280.70K |
| Total Depreciation and Amortization | 904.60K | 799.80K | 673.50K | 565.10K | 459.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 277.20K | 347.00K | 296.70K | -313.70K | 81.50K |
| Change in Net Operating Assets | -281.00K | -587.70K | 1.54M | 768.50K | 12.00K |
| Cash from Operations | 134.80K | -603.90K | 1.43M | 1.14M | 272.20K |
| Capital Expenditure | 1.38M | 1.41M | 1.45M | 1.47M | -39.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.15M | -7.64M | -7.64M | -18.79M | -12.88M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.23M | -3.75M | -3.74M | -1.51M | -1.51M |
| Cash from Investing | -8.00M | -9.98M | -9.93M | -18.83M | -14.43M |
| Total Debt Issued | 3.16M | 3.16M | 3.16M | -- | -- |
| Total Debt Repaid | -357.00K | -367.80K | -312.00K | -202.30K | -182.00K |
| Issuance of Common Stock | 21.44M | 21.44M | 21.44M | 3.16M | 7.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.03M | 806.30K | 431.80K | -18.20K | -- |
| Cash from Financing | 18.16M | 17.99M | 17.76M | 2.14M | 5.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.30M | 7.40M | 9.26M | -15.55M | -8.69M |